HUNTINGTON NATIONAL BANK - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2018$0
-100.0%
80
-92.0%
0.00%
Q1 2018$3,0000.0%1,0000.0%0.00%
Q4 2017$3,0000.0%1,0000.0%0.00%
Q3 2017$3,000
+50.0%
1,0000.0%0.00%
Q2 2017$2,000
-97.4%
1,000
-91.8%
0.00%
-100.0%
Q2 2015$78,000
-74.8%
12,143
-70.6%
0.00%
-66.7%
Q3 2014$309,000
-40.9%
41,300
-23.5%
0.01%
-40.0%
Q2 2014$523,000
+16.5%
54,0000.0%0.01%
+11.1%
Q1 2014$449,000
+3107.1%
54,000
+2600.0%
0.01%
Q4 2012$14,000
-6.7%
2,0000.0%0.00%
-100.0%
Q3 2012$15,000
+114.3%
2,000
+100.0%
0.00%
Q2 2012$7,0001,0000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders